Vaccines for the Prevention of HIV-1 Acquistion and Viral Control
Peter Doherty Institute
This presentation explores current HIV preventive vaccine research and development efforts. It will touch on those based on the only HIV vaccine trial to demonstrate efficacy – the RV 144 trial in Thailand – as well as newer approaches that could lead to a universal HIV vaccine.
This final Doherty Institute Seminar for 2017 will be presented by Colonel Nelson L Michael from Walter Reed Army Institute of Research.
Dr Nelson Michael, Director Military HIV Research Program
Dr Nelson Michael
Director Military HIV Research Program
the Walter Reed Army Institute of Research (WRAIR)
Nelson L. Michael, M.D., Ph.D serves as Director, Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research (WRAIR), an HIV vaccine research program that successfully integrates HIV/AIDS prevention, care and treatment. A Colonel in the United States Army, he is also the WRAIR Deputy Commander. Dr. Michael guided MHRP through the completion of the RV144 HIV vaccine study which demonstrated that a preventive HIV vaccine was possible. Dr. Michael's research interests include HIV molecular pathogenesis, host genetics, and HIV/Ebola/MERS CoV and ZIKV vaccine development. He is a Professor of Medicine, Uniformed Services University and has coauthored more than 300 publications. Dr. Michael graduated summa cum laude from University of California, Los Angeles in 1979 with a degree in biology and from Stanford University with M.D. and Ph.D. (cancer biology) degrees in 1986. He trained in internal medicine at Harvard Medical School, Massachusetts General Hospital from 19861989.